K. Altundağ

Mustafa A. Atik, O. Altundag, C. Boruban, 2006, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.

Heparin and CXCL12 dimerization.

Mustafa A. Atik, O. Altundag, K. Altundağ, 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Sonographic and electrodiagnostic evaluations in patients with aromatase inhibitor-related arthralgia.

H. Harputluoglu, Y. Ozisik, O. Dizdar, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Optimal timing of adjuvant treatment in patients with early breast cancer

F. Onder, A. Ulaş, S. Muallaoğlu, 2011, Medical oncology.

Variation in hormone receptor and HER-2 status between primary and metastatic breast cancer: review of the literature

S. Aksoy, E. Sarı, Ç. Arslan, 2011, Expert opinion on therapeutic targets.

Comparison of three different induction regimens for nasopharyngeal cancer.

M. Cengiz, G. Yazici, T. Babacan, 2015, Asian Pacific journal of cancer prevention : APJCP.

H. Harputluoglu, O. Dizdar, S. Kılıçkap, 2007, Leukemia & lymphoma.

Clinical Associations with ABO Blood Group and Rhesus Blood Group Status in Patients with Breast Cancer: A Nationwide Retrospective Study of 3,944 Breast Cancer Patients in Turkey

S. Akın, K. Altundağ, 2018, Medical science monitor : international medical journal of experimental and clinical research.

Definition of postmenopausal status, age of the breast cancer patients and the outcome of aromatase inhibitors treatment.

O. Dizdar, S. Aksoy, K. Altundağ, 2008, Breast.

Primary breast cancer phenotypes associated with propensity for central nervous system metastases

K. Altundağ, 2006, Cancer.

Characteristics of breast cancer patients with central nervous system metastases: a single-center experience.

H. Harputluoglu, Y. Ozisik, N. Guler, 2008, Journal of the National Medical Association.

Serum Lactate Dehydrogenase Level is a Prognostic Factor in Patients with Locoregionally Advanced Nasopharyngeal Carcinoma Treated with Chemoradiotherapy

E. Ozyar, I. Gullu, S. Turen, 2007, Cancer investigation.

Insomnia caused by aromatase inhibitors; a therapeutic challenge in patients with breast cancer.

A. Sever, S. Şahin, T. Babacan, 2015, Journal of B.U.ON. : official journal of the Balkan Union of Oncology.

Secondary hematological malignancies after treatment of non-metastatic breast cancer.

Y. Ozisik, Ç. Arslan, E. Doğan, 2011, Journal of B.U.ON. : official journal of the Balkan Union of Oncology.

Peripheral T-cell lymphoma and Job's syndrome

M. Kurt, I. Onal, M. Dinçer, 2006, Medical oncology.

Do Yoga and Aerobic Exercise Training Have Impact on Functional Capacity, Fatigue, Peripheral Muscle Strength, and Quality of Life in Breast Cancer Survivors?

M. Sağlam, H. Arikan, S. Savcı, 2015, Integrative cancer therapies.

Herpes simplex type-2 encephalitis masked by diabetic ketoacidosis.

Y. Aydın, D. Berker, S. Guler, 2005, Journal of the National Medical Association.

Thymic epithelial neoplasia

Y. Ozisik, M. Erman, H. Abalı, 2007, Medical oncology.

Is there an association between high heparanase level and osteoporosis risk in breast cancer patients without clinical evidence of bone metastases?

Mustafa A. Atik, O. Altundag, M. Baptista, 2005, Osteoporosis International.

Re: Dietary fat reduction and breast cancer outcome: interim efficacy results from the Women's Intervention Nutrition Study.

M. Kurt, K. Altundağ, 2007, Journal of the National Cancer Institute.

Does zoledronic acid have additive effect on suppression of plasma estrogen levels?

N. Zengi̇n, S. Aksoy, M. Şendur, 2013, Asian Pacific journal of cancer prevention : APJCP.

Coffee and breast cancer risk

O. Altundag, M. Baptista, K. Altundağ, 2006, International journal of cancer.

5-Fluorouracil-Induced Coronary Spasm: May Inhibition of Hyperpolarization Factors Produced by CYP2C Enzymes Be the Cause?

U. Yasar, M. Babaoğlu, O. Karadag, 2004, Oncology.

Cytokines and chemokines as predictive markers in non-small cell lung cancer patients with brain metastases.

P. Morandi, M. Gunduz, O. Altundag, 2005, Lung cancer.

Breast cancer in octogenarian women: clinical characteristics and outcome.

N. Zengi̇n, O. Dizdar, O. Altundag, 2013, Journal of B.U.ON. : official journal of the Balkan Union of Oncology.

Renal safety of zoledronic acid administration beyond 24 months in breast cancer patients with bone metastases

H. Harputluoglu, M. Cengiz, M. Dinçer, 2008, Medical oncology.

Extranodular extension in sentinel lymph node-positive breast cancer might predict further initiation of completion axillary lymph node dissection

K. Altundağ, 2018, Breast Cancer Research and Treatment.

Increased cabbage intake may inhibit metastatic and invasive capacity of breast cancer cells by inhibiting CXCL12(SDF-1 alpha)/CXCR4.

O. Altundag, Ozlem A Gundeslioglu, K. Altundağ, 2006, Medical hypotheses.

Possible role of CXCR4-mediated chemotaxis in breast cancer patients with central nervous system metastases

P. Morandi, M. Gunduz, O. Altundag, 2005, Breast Cancer Research and Treatment.

Are all basal-like breast cancers associated with worse prognosis?

K. Altundağ, 2017, Breast.

Have all triple-negative breast cancer patients worse breast cancer-specific survival?

K. Altundağ, 2017, Breast.

Association between obesity and multiple myeloma in postmenopausal women may be attributed to increased aromatization of androgen in adipose tissue.

M. Kurt, O. Altundag, R. Islam, 2005, Medical hypotheses.

Prognostic Significance of Obesity and Diabetes Mellitus in Women With Brain Metastases From Breast Cancer Should Be Revisited.

K. Altundağ, 2019, Clinical breast cancer.

The results of hypofractionated radiotherapy in 31 patients with high-grade gliomas

B. Kaya, M. Altundağ, B. Bakkal, 2007, Medical oncology.

Tamoxifen may increase insulin requirement in breast cancer patients with type 1 diabetes mellitus through its agonistic activity on splenic endothelial cells and inhibitory effect on pancreatic beta cells.

M. Kurt, O. Altundag, S. Turen, 2005, Medical hypotheses.

Taxane Followed by Anthracycline or Vice Versa: Impact of Sequential Order on Breast Cancer Recurrence?

K. Altundağ, 2017, JAMA oncology.

Clinicopathological features of patients with breast cancer aged 70 years or over.

S. Şahin, A. Aytekin, G. Erdem, 2017, Journal of B.U.ON. : official journal of the Balkan Union of Oncology.

Brain Metastasis of Cardiac Myxoma: Case Report and Review of the Literature

B. Kaya, T. Çalikoglu, Sema Durmuş, 2005, Journal of Neuro-Oncology.

The role of aromatase inhibitors in the management of ductal carcinoma in situ with an estrogen receptor-positive/progesterone receptor-negative/Her-2/neu receptor-positive pattern.

H. Harputluoglu, N. Bulut, E. Sarı, 2007, American journal of surgery.

Osteonecrosis of the jaw in patients receiving intravenous bisphosphonate therapy.

G. Hortobagyi, A. Nooka, B. Toth, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Acute tumor lysis syndrome triggered by zoledronic acid in a patient with metastatic lung adenocarcinoma

M. Kurt, B. Altun, I. Onal, 2005, Medical oncology.

SRL172 (killed Mycobacterium vaccae) may augment the efficacy of trastuzumab in metastatic breast cancer patients.

O. Altundag, E. Gunduz, Y. Silay, 2005, Medical hypotheses.

Aromatase inhibitor-associated arthralgias: Pathogenesis, frequency and management.

H. Harputluoglu, I. Gullu, D. Dede, 2007, Joint, bone, spine : revue du rhumatisme.

Epithelioid sarcoma of vulva

A. Usubutun, O. Dikbas, B. Oyan, 2004, Medical oncology.

Closure of large scalp defects by modified Gillies triple scalp flaps in patients with scalp tumors.

O. Altundag, Ş. Akın, T. Maral, 2005, Plastic and reconstructive surgery.

Global warming may increase the incidence and geographic range of Crimean-Congo Hemorrhagic Fever.

T. Purnak, K. Altundağ, N. A. Selvi, 2007, Medical hypotheses.

Frequency of HCV infection in renal cell carcinoma patients

N. Zengi̇n, B. Öksüzoğlu, N. Babacan, 2012, Medical Oncology.

Efficacy of Capecitabine Monotherapy as the First-line Treatment of Metastatic HER2-negative Breast Cancer

Fatih Demirci, A. Sever, E. Esin, 2015, Tumori.

Does the sequence of taxane administration affect the outcome of patients with breast cancer in the adjuvant and neoadjuvant settings?

U. Şahin, A. Alkan, K. Altundağ, 2010, Medical oncology.

More data along with further definitions are required.

A. Sever, S. Şahin, A. Aytekin, 2016, Breast.

Efficacy and safety of eribulin monotherapy in patients with heavily pretreated metastatic breast cancer.

Y. Ozisik, A. Sever, T. Babacan, 2015, Journal of B.U.ON. : official journal of the Balkan Union of Oncology.

Dermatitis artefacta in a patient with recurrent larynx cancer: a rare self-inflicted dermatosis.

O. Dikbas, B. Isık, M. Işık, 2004, Southern medical journal.

Breast arterial calcification is associated with an increased prevalence of both cardiovascular risk factors and cardiovascular morbidity.

H. Harputluoglu, O. Dizdar, O. Kara, 2008, Menopause.

Uracil-tegafur in early-stage lung cancer.

M. Gunduz, O. Altundag, K. Altundağ, 2004, The New England journal of medicine.

Her2 positive subtype and breast cancer brain metastasis: any effect of anti-Her2 targeted therapy?

K. Altundağ, 2017, Journal of Neuro-Oncology.

Clinical implications of intratumoral heterogeneity of HER2 gene amplification in locally advanced HER2-positive breast cancer patients.

A. Sever, B. Hacioglu, S. Akın, 2015, Future oncology.

Cyclophosphamide-Associated Carcinoma of the Urinary Bladder in Behçet’s Disease

M. Erman, I. Çelik, E. Baltalı, 1999, Nephron.

Treatment of recurrent cerebellar hemangioblastoma with external radiotherapy in a patient with von Hippel-Lindau disease: a case report and review of the literature

F. Cankal, M. Altundağ, Gulçin Ertaş, 2005, Journal of Neuro-Oncology.

Chemotherapy during Pregnancy: Cases of Hodgkin's and Non-Hodgkin's Lymphoma, Chronic Myeloid Leukemia, Breast Cancer, Nasopharyngeal Cancer, and Choriocarcinoma

O. Ozyuncu, M. Beksaç, Gokcen Orgul, 2017, Oncology Research and Treatment.

Pathological characteristics of very young (< or = 30 years) breast cancer patients: a single-institution experience from Turkey.

O. Dizdar, S. Aksoy, N. Bulut, 2009, Annals of oncology : official journal of the European Society for Medical Oncology.

Luminal subtypes and response to neoadjuvant chemotherapy for hormone receptor-positive HER2-negative patients

K. Altundağ, 2020, Breast Cancer Research and Treatment.

Perioperative Tamoxifen Use and Risk of Deep Vein Thrombosis: Role of Caprini Risk Assessment Model Should Not Be Discarded.

K. Altundağ, 2017, Annals of plastic surgery.

Treatment of thymoma and prognostic factors: In regard to Zhu et al. (Int J Radiat Oncol Biol Phys 2004;60:1113-1119).

P. Morandi, O. Yiğitbaşı, O. Altundag, 2005, International journal of radiation oncology, biology, physics.

Ifosfamide and doxorubicin combination chemotherapy for recurrent nasopharyngeal carcinoma patients.

M. Cengiz, I. Gullu, S. Aksoy, 2012, Asian Pacific journal of cancer prevention : APJCP.

Safety and efficacy of transdermal fentanyl in patients with cancer pain: phase IV, Turkish oncology group trial.

B. Demirkan, F. Ozdemir, A. Yavuz, 2007, European journal of cancer care.

Secretory carcinoma of the breast in postmenopausal women.

K. Altundağ, 2020, Journal of B.U.ON. : official journal of the Balkan Union of Oncology.

Is it feasible to adjust bisphosphonate dose according to bone mineral density value in postmenopausal breast cancer patients with bone metastases?

K. Altundag, T. Delibaşı, O. Altundag, 2006, Medical hypotheses.

Patients’ understanding of treatment goals and disease course and their relationship with optimism, hope, and quality of life: a preliminary study among advanced breast cancer outpatients before receiving palliative treatment

K. Altundag, A. Sever, T. Babacan, 2016, Supportive Care in Cancer.

Comparison of the long term cardiac effects associated with 9 and 52 weeks of trastuzumab in HER2-positive early breast cancer

O. Yazıcı, N. Zengi̇n, K. Aytemir, 2015, Current medical research and opinion.

Comparative study of the immunohistochemical detection of hormone receptor status and HER-2 expression in primary and paired recurrent/metastatic lesions of patients with breast cancer

K. Altundag, Y. Ozisik, G. Guler, 2011, Medical oncology.

Warfarin-induced skin necrosis and leukocytoclastic vasculitis in a patient with acquired protein C and protein S deficiency.

S. Aksu, M. Kurt, I. Haznedaroglu, 2007, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

The association between body mass index and immunohistochemical subtypes in breast cancer.

Y. Ozisik, A. Sever, S. Şahin, 2017, Breast.

Association of breast cancer subtypes and body mass index.

U. Şahin, O. Dizdar, D. Yuce, 2013, Tumori.

Demographic, clinical, and pathological characteristics of Turkish triple-negative breast cancer patients: single center experience.

H. Harputluoglu, O. Dizdar, S. Aksoy, 2007, Annals of oncology : official journal of the European Society for Medical Oncology.

Recurrent Cholestasis Due to Ampicillin

S. Köklü, L. Filik, O. Yüksel, 2003, The Annals of pharmacotherapy.

Management of hair loss associated with endocrine therapy in patients with breast cancer: an overview

K. Altundag, A. Sever, S. Şahin, 2016, SpringerPlus.

Association of Breast Cancer Subtypes and Body Mass Index

U. Şahin, O. Dizdar, D. Yuce, 2013 .

Evaluating the World Health Organization’s International Classification of Functioning, Disability and Health Framework as a Participation Model for Cancer Survivors in Turkey

J. Bezyak, Fong Chan, T. Tansey, 2018, Rehabilitation Counseling Bulletin.

Behcet's Disease and Breast Cancer

I. Petekkaya, E. Roach, K. Altundağ, 2014, The breast journal.

Frequency and Risk Factors Associated With Osteonecrosis of the Jaw in Cancer Patients Treated With Intravenous Bisphosphonates

G. Hortobagyi, K. Altundag, C. Warneke, 2008, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Sublingual piroxicam for cancer pain

G. Tekuzman, Mehmet Asıl, K. Altundağ, 1998, Medical oncology.

Pericardial Tamponade in a Patient with Thalassemia Major due to Hypothyoridism

Y. Aydın, I. Ustun, K. Altundağ, 2006, Acta Haematologica.

A novel targeted therapy in breast cancer: cyclin dependent kinase inhibitors.

T. Babacan, F. Sarici, S. Akın, 2014, Journal of B.U.ON. : official journal of the Balkan Union of Oncology.

Everolimus: a new hope for patients with breast cancer

N. Zengi̇n, S. Aksoy, M. Şendur, 2014, Current medical research and opinion.

Review Everolimus: a new hope for patients with breast cancer

N. Zengi̇n, S. Aksoy, M. Şendur, 2014 .

Aromatase inhibitors in breast cancer: an overview.

N. Ibrahim, Nuhad K Ibrahim, Kadri Altundag, 2006, The oncologist.

Cardiotoxicity of novel HER2-targeted therapies

S. Aksoy, M. A. Şendur, K. Altundağ, 2013, Current medical research and opinion.

The significance of heat shock proteins in breast cancer therapy

B. Halaçlı, Sevil OSKAY HALACLI, K. Altundağ, 2013, Medical Oncology.

Lymphatic and Capillary Invasion Patterns in Triple Negative Breast Cancer

G. Guler, S. Aksoy, Ş. Yaman, 2012, The American surgeon.

Demographic and clinico-pathological characteristics in patients with invasive breast cancer receiving metformin

S. Aksoy, K. Altundağ, M. Şendur, 2013, Medical Oncology.

Association between common risk factors and molecular subtypes in breast cancer patients.

Y. Ozisik, Z. Arık, T. Babacan, 2013, Breast.

US and CT findings of multicentric leiomyosarcomatosis

M. Özmen, A. Aralaşmak, İ. Güllü, 1999, European Radiology.

Synchronous presentation of nasopharyngeal and renal cell carcinomas.

C. Boruban, O. Şencan, Ozlem Yavas, 2006, International braz j urol : official journal of the Brazilian Society of Urology.

CD40 signaling predicts response to preoperative trastuzumab and concomitant paclitaxel followed by 5-fluorouracil, epirubicin, and cyclophosphamide in HER-2-overexpressing breast cancer

Jing Wang, G. Hortobagyi, L. Pusztai, 2007, Breast Cancer Research.

Primary gastric choriocarcinoma.

O. Ates, K. Altundağ, Ibrahim Gullu, 2018, Journal of B.U.ON. : official journal of the Balkan Union of Oncology.

Manipulating the chemokine‐chemokine receptor network to treat cancer

M. Cristofanilli, P. Morandi, N. Cabioğlu, 2007, Cancer.

From endometrial hyperplasia to endometrial cancer: insight into the biology and possible medical preventive measures

K. Altundag, M. C. Boruban, G. Kilic, 2008, European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation.

Efficacy of dose dense doxorubicin and cyclophosphamide followed by paclitaxel versus conventional dose doxorubicin, cyclophosphamide followed by paclitaxel or docetaxel in patients with node-positive breast cancer.

O. Yazıcı, N. Zengi̇n, S. Aksoy, 2015, Asian Pacific journal of cancer prevention : APJCP.

Emerging drugs in metastatic breast cancer

O. Dizdar, K. Altundağ, 2009 .

Prognostic role of inflammatory biomarkers in metastatic breast cancer.

K. Altundag, O. Unlu, E. Petekkaya, 2017, Journal of B.U.ON. : official journal of the Balkan Union of Oncology.

Use of Oral Cyclophosphamide for Antiangiogenic Therapy in Recurrent Aggresive Giant Cell Lesion of the Mandible

I. Vargel, M. Akkocaoglu, B. Çil, 2008 .

Molecular subtypes in patients with inflammatory breast cancer; a single center experience.

Y. Ozisik, Z. Arık, T. Babacan, 2015, Journal of B.U.ON. : official journal of the Balkan Union of Oncology.

Ductal Carcinoma in Situ and Bilateral Atypical Ductal Hyperplasia in a 23-Year-Old Man with Gynecomastia

K. Altundag, G. Gunaydin, K. Altundağ, 2011, The American surgeon.

Anterior abdominal wall synovial sarcoma: a rare presentation.

O. Karadag, O. Dikbas, G. Gedıkoğlu, 2005, American journal of clinical oncology.

Association between family history and clinicopathologic characteristics in 1987 breast cancer patients: single institution experience from Turkey.

K. Altundag, Y. Ozisik, Z. Arık, 2012, Journal of B.U.ON. : official journal of the Balkan Union of Oncology.

Evaluation of cardiac safety of lapatinib therapy for ErbB2-positive metastatic breast cancer: A single center experience

Y. Ozisik, N. Ozer, H. Yorgun, 2012, Medical Oncology.

Pharmacotherapy of triple-negative breast cancer

O. Dizdar, Ç. Arslan, K. Altundağ, 2009, Expert opinion on pharmacotherapy.

Vitamin D intake and breast cancer risk in postmenopausal women.

H. Harputluoglu, O. Dizdar, K. Altundağ, 2007, Archives of internal medicine.

Variations in tumor marker levels in metastatic breast cancer patients according to tumor subtypes.

Z. Arık, N. Zengi̇n, S. Aksoy, 2013, Journal of B.U.ON. : official journal of the Balkan Union of Oncology.

Chemotherapy might not be beneficial in lymph node- negative, hormone-positive, and HER2-negative breast cancer patients: a long-term retrospective analysis.

T. Babacan, N. Kertmen, Y. Karakaş, 2015, Journal of B.U.ON. : official journal of the Balkan Union of Oncology.

Angiotensin-Converting Enzyme Inhibitors for Bevacizumab-Induced Hypertension

K. Altundag, M. Dinçer, K. Altundağ, 2006, The Annals of pharmacotherapy.

Systemic anaphylactic reaction following intrathecal administration of methotrexate in adult patient with primary central nervous system lymphoma

I. Onal, G. Tekuzman, S. Aksoy, 2004, American journal of hematology.

Superior Vena Cava Thrombosis in Chronic Lead Exposure

D. Aksoy, S. Köklü, C. Usalan, 2003, Angiology.

A Phase II Study on the Safety and Efficacy of 5-Fluorouracil, Epirubicin, Cyclophosphamide (FEC) Followed by Paclitaxel in the Adjuvant Treatment of Breast Cancer

K. Altundag, Y. Ozisik, N. Guler, 2005, Cancer investigation.

Tobacco Smoking and Breast Cancer

O. Altundag, M. Baptista, S. Akyurek, 2006, The breast journal.

Brucella Glomerulonephritis: Case Report and Review of the Literature

S. Guler, I. Ustun, M. Duranay, 2005, Southern medical journal.

What is the mechanism of progression with trastuzumab treatment--escape or resistance?

N. Zengi̇n, S. Aksoy, N. Özdemir, 2012, Asian Pacific journal of cancer prevention : APJCP.

Assessment of psychosocial factors and distress in women having adjuvant endocrine therapy for breast cancer: the relationship among emotional distress and patient and treatment-related factors

A. Sever, T. Babacan, N. Kertmen, 2016, SpringerPlus.

Triple negative endometrial cancer may be more sensitive to platinum based chemotherapy.

O. Altundag, P. Dursun, E. Roach, 2013, Journal of B.U.ON. : official journal of the Balkan Union of Oncology.

Free circulating DNA: good as a diagnostic marker in lung cancer?

K. Altundag, O. Altundag, M. Altundağ, 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Osteonecrosis of the Jaw or Maxilla after Intravenous Bisphosphonates for Multiple Myeloma and Breast Cancer: Long-Term Follow-Up Shows a Slow Rate of Healing.

G. Hortobagyi, C. Warneke, A. Nooka, 2006 .

Safety of Tamoxifen During Pregnancy: 3 Case Reports and Review of the Literature

T. Babacan, I. Turkbeyler, T. Y. Kuzan, 2013, Breast Care.

C. Shapiro, S. Costinean, K. Huebner, 2012, Modern Pathology.

Evaluation of changes in biologic markers ER, PR, HER 2 and Ki-67 index in breast cancer with administration of neoadjuvant dose dense doxorubicin, cyclophosphamide followed by paclitaxel chemotherapy.

K. Altundag, Y. Ozisik, G. Guler, 2013, Journal of B.U.ON. : official journal of the Balkan Union of Oncology.

Emerging drugs in metastatic breast cancer: an update

O. Dizdar, Ç. Arslan, K. Altundağ, 2011, Expert opinion on emerging drugs.

Do metastasis-free interval less or more than 24 months for recurrent metastatic breast cancer and primary surgery for de novo metastatic breast cancer matter for survival?

K. Altundağ, 2017, Breast Cancer Research and Treatment.

Does Androgen Receptor Have a Prognostic Role in Patients with Estrogen/Progesterone-Negative and c-erbB-2-Positive Breast Cancer?

K. Altundag, Y. Ozisik, G. Guler, 2012, The American surgeon.

Mucosa associated lymphoid tissue lymphoma of the sub-mandibular gland presenting with relapse in the lacrimal gland

O. Dizdar, M. Kurt, I. Gullu, 2006, Leukemia & lymphoma.

Current and emerging treatment options in triple-negative breast cancer

O. Dizdar, K. Altundağ, 2011 .

Outcome of 561 non-metastatic triple negative breast cancer patients: multi-center experience from Turkey.

H. Harputluoglu, U. Coşkun, B. Budakoğlu, 2014, Journal of B.U.ON. : official journal of the Balkan Union of Oncology.

Aspirin intake may prevent metastasis in patients with triple-negative breast cancer

I. Sahin, E. Ararat, K. Altundağ, 2011, Medical oncology.

Impact of inflammatory markers on the prognosis of patients with operable breast cancer.

K. Altundag, E. Petekkaya, A. Okoh, 2014, Journal of B.U.ON. : official journal of the Balkan Union of Oncology.

Invasive Pleomorphic Lobular Histology is an Adverse Prognostic Factor on Survival in Patients with Breast Cancer

S. Şahin, G. Erdem, Fatih Karataş, 2017, The American surgeon.

Review Cardiotoxicity of novel HER2-targeted therapies

S. Aksoy, M. Şendur, K. Altundağ, 2013 .

Favorable results of patients with pT1a, b, c, lymph node-negative early breast cancer in the long interval

K. Altundag, A. Ulaş, N. Bulut, 2019, Journal of cancer research and therapeutics.

The prognostic impact of obesity on molecular subtypes of breast cancer in premenopausal women.

K. Altundag, Y. Ozisik, Z. Arık, 2013, Journal of B.U.ON. : official journal of the Balkan Union of Oncology.

Trastuzumab emtansine (T-DM1) for HER2-positive breast cancer

T. Babacan, M. C. Kızılarslanoğlu, S. Aksoy, 2013, Current medical research and opinion.

Review Trastuzumab emtansine (T-DM1) for HER2-positive breast cancer

T. Babacan, M. C. Kızılarslanoğlu, S. Aksoy, 2013 .

Pertuzumab in HER2-positive breast cancer

S. Aksoy, M. Şendur, K. Altundağ, 2012, Current medical research and opinion.

Review article Pertuzumab in HER2-positive breast cancer

S. Aksoy, K. Altundağ, 2012 .

Quilting Sutures after Latissimus Dorsi Breast Reconstruction in Breast Cancer Patients Might Lead to Reduced Risk of Developing Arm Lymphedema by Reducing Seroma Risk.

K. Altundağ, 2017, Plastic and reconstructive surgery.

The role of aromatase inhibitors in the adjuvant treatment of breast carcinoma

G. Hortobagyi, R. Theriault, A. Buzdar, 2004, Cancer.

Effect of body mass index on the efficacy of adjuvant tamoxifen in premenopausal patients with hormone receptor-positive breast cancer.

K. Altundag, O. Yazıcı, N. Zengi̇n, 2016, Journal of B.U.ON. : official journal of the Balkan Union of Oncology.

Two important determinants may play a role in the success of the FinHer Trial.

O. Dizdar, M. Işık, K. Altundağ, 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Serum 25-hydroxy vitamin D status is not related to osteopenia/osteoporosis risk in colorectal cancer survivors.

O. Yazıcı, N. Zengi̇n, S. Aksoy, 2014, Asian Pacific journal of cancer prevention : APJCP.

Fanconi's anemia and squamous cell carcinoma of the larynx

O. Dikbas, Z. Ülger, B. Karaca, 2003, Annals of Hematology.

DNA methylation inhibitor, procainamide, may decrease the tamoxifen resistance by inducing overexpression of the estrogen receptor beta in breast cancer patients.

M. Gunduz, O. Altundag, K. Altundağ, 2004, Medical hypotheses.

Estrogen or testosterone may be effective agents in the management of both multiple myeloma and Alzheimer's disease.

M. Ozen, N. Bulut, M. Tezcan, 2007, Medical hypotheses.

Metaplastic breast carcinoma: a heterogeneous disease.

K. Altundag, Y. Ozisik, N. Guler, 2014 .

Impact of the obesity on lymph node status in operable breast cancer patients.

K. Altundag, Z. Arık, E. Esin, 2013, Journal of B.U.ON. : official journal of the Balkan Union of Oncology.

Malignant Hypercalcemia in a Patient with Maxillary Sinus Squamous Cell Carcinoma without Skeletal Metastases

O. Varan, E. Doğan, G. Ozen, 2010, The American surgeon.

Secondary malignancies mimicking primary pancreatic lymphoma

E. Petekkaya, M. Karçaaltıncaba, I. Petekkaya, 2014 .

Primary pancreatic lymphoma or secondary involvement: what is the difference?

T. Kav, Y. Bayraktar, K. Altundağ, 2010, JOP : Journal of the pancreas.

Pituitary Gland Metastasis of Breast Cancer: A Case Report

M. Kılıç, M. Erman, Ç. Arslan, 2012 .

Serum and plasma vascular endothelial growth factor levels in testicular cancer patients

O. Altundag, M. Altundağ, K. Altundağ, 2004 .

Dasatinib may also inhibit c-Kit in triple negative breast cancer cell lines

O. Dizdar, N. Bulut, D. Dede, 2007, Breast Cancer Research and Treatment.

Maxillary Sinus Carcinoma Metastases Mimicking Malignant Pleural Mesothelioma

O. Kara, Ç. Arslan, S. Onder, 2010, The American surgeon.

Lactation, galactorrhea, and timing of reduction mammaplasty.

O. Altundag, H. Borman, Ozlem A Gundeslioglu, 2006, Plastic and reconstructive surgery.

I. Sahin, M. C. Kızılarslanoğlu, S. Aksoy, 2011, Journal of B.U.ON. : official journal of the Balkan Union of Oncology.

Interleukin-2-induced reversible hyperbilirubinemia and cholestasis in a patient with Gilbert's syndrome

H. Engin, K. Altundağ, Berna Çakmak Öksüzoğlu, 2002, Journal of gastroenterology.

Probable sorafenib-induced reversible encephalopathy in a patient with hepatocellular carcinoma

S. Aksoy, Ç. Arslan, E. Doğan, 2010, Medical oncology.

Myasthenia Gravis and Lymphoblastic Lymphoma Involving the Thymus: A Rare Association

E. Tan, N. Güler, H. Abalı, 2001, Leukemia & lymphoma.

Isolated metastasis of malignant melanoma into follicular carcinoma of the thyroid gland

S. Aksoy, A. Sağlam, A. Üner, 2004, Journal of endocrinological investigation.

Maintenance therapy with alpha‐interferon following first‐line VAD in multiple myeloma

N. Zengi̇n, E. Kansu, M. Hayran, 1997, European Journal of Haematology.

Acquired C1 esterase inhibitor deficiency in a marginal zone lymphoma patient treated with rituximab.

T. Babacan, N. Kertmen, V. Sunar, 2015, Journal of B.U.ON. : official journal of the Balkan Union of Oncology.

Hepatotoxicity due to a possible interaction between cytosine arabinoside and dipyridamole: a case report

U. Yasar, M. Babaoğlu, O. Karadag, 2004, European Journal of Clinical Pharmacology.

Cyclooxygenase inhibitors may be more effective in hormone-dependent endometrial cancers: interaction between cyclooxygenase and aromatase.

K. Altundag, P. Morandi, O. Altundag, 2005, Annals of oncology : official journal of the European Society for Medical Oncology.

A comprehensive review of denosumab for bone metastasis in patients with solid tumors

K. Altundag, A. Sever, S. Aksoy, 2016, Current medical research and opinion.

Isolated hyperbilirubinemia following standard dose cytosine arabinoside in a patient with relapsed acute myeloid leukemia

O. Altundag, I. Çelik, A. Kars, 2004, American journal of hematology.

Atezolizumab and Nab-Paclitaxel in Advanced Triple-Negative Breast Cancer.

K. Altundağ, 2019, The New England journal of medicine.

Fluorouracil-induced neurotoxicity presenting with generalized tonic–clonic seizure

N. Guler, Y. Beyazit, A. Kars, 2004, The Annals of pharmacotherapy.

Risk factors and histopathological features of breast cancer among women with different menopausal status and age at diagnosis.

O. Unlu, T. Babacan, H. G. Yavas, 2017, Journal of B.U.ON. : official journal of the Balkan Union of Oncology.

The efficacy of adjuvant trastuzumab in HER-2 positive breast cancer with axillary lymph node metastases according to the treatment duration

O. Yazıcı, N. Zengi̇n, S. Aksoy, 2014, Current medical research and opinion.

Comparative study of receptor discordance between primary and corresponding metastatic lesions in breast cancer.

K. Altundag, Y. Bozkaya, N. Zengi̇n, 2017, Journal of B.U.ON. : official journal of the Balkan Union of Oncology.

Chemotherapy and biological treatment options in breast cancer patients with brain metastasis: an update

K. Altundag, O. Dizdar, Ç. Arslan, 2014, Expert opinion on pharmacotherapy.

Breast cancer subtypes and outcomes of central nervous system metastases.

H. Harputluoglu, Y. Ozisik, N. Zengi̇n, 2011, Breast.

Clinicopathologic characteristics and prognostic factors in 420 metastatic breast cancer patients with central nervous system metastasis

G. Hortobagyi, M. Bondy, K. Broglio, 2007, Cancer.

Evaluating The Clinicopathologic Characteristics and Survival Outcome of Breast Cancer Patients with Isolated Brain Metastases after Adjuvant Treatment or at Initial Diagnosis

K. Altundag, M. Cengiz, M. Artaç, 2012 .

Combination of Docetaxel and Doxorubicin as First-Line Chemotherapy in Metastatic Breast Cancer

N. Güler, E. Baltalı, D. Firat, 2001, Tumori.

Treatment of advanced soft tissue sarcomas with ifosfamide and doxorubicin combination chemotherapy

K. Altundag, N. Zengi̇n, N. Güler, 2000, Journal of surgical oncology.

Increased Mean Corpuscular Volume of Erythrocytes during Capecitabine Treatment: A Simple Surrogate Marker for Clinical Response

Y. Ozisik, N. Guler, O. Dizdar, 2011 .

Increased mean corpuscular volume of erythrocytes during capecitabine treatment: a simple surrogate marker for clinical response.

Y. Ozisik, O. Dizdar, M. Kurt, 2011, Tumori.

Systemic treatment in breast-cancer patients with brain metastasis

O. Dizdar, Ç. Arslan, K. Altundağ, 2010, Expert opinion on pharmacotherapy.

Patient perspective on sequence order of anthracyclines and taxanes in neoadjuvant chemotherapy in HER2-negative breast cancer patients.

K. Altundağ, 2021, Journal of B.U.ON. : official journal of the Balkan Union of Oncology.

Superiority of letrozole over tamoxifen in the first-line treatment of metastatic breast cancer patients with normal serum Her-2/neu levels: question of tamoxifen resistance.

O. Altundag, K. Altundağ, 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Trastuzumab 1-year vs 9-week in early-stage HER2-positive, lymph node negative breast cancer patients.

Y. Ozisik, M. Ozen, A. Sever, 2016, Journal of B.U.ON. : official journal of the Balkan Union of Oncology.

Adjuvant use of epidermal growth factor receptor kinase inhibitors may prevent bone metastases in patients with non-small cell lung carcinoma.

H. Harputluoglu, K. Altundag, O. Dizdar, 2007, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

The Clinicopathological Characteristics of Pure and Mixed Invasive Micropapillary Breast Carcinomas: A Single Center Experience

K. Altundağ, Gülnihan Eren Kupik, 2022, Balkan medical journal.

Is initially metastatic breast carcinoma different from recurrent metastatic breast carcinoma?

O. Dizdar, S. Aksoy, K. Altundağ, 2009, Annals of Oncology.

De-escalating systemic chemotherapy might be considered for pure triple negative apocrine breast cancer patients.

K. Altundağ, 2019, Journal of B.U.ON. : official journal of the Balkan Union of Oncology.

Metaplastic breast cancer: Some concerns about hormone receptor status and treatment schedules

K. Altundağ, 2019, The breast journal.

Pure Mucinous Breast Carcinoma with Lung Metastasis in a Young Male Patient

N. Kertmen, E. Doğan, K. Altundağ, 2010, The American surgeon.

Obesity may decrease the amenorrhea associated with chemotherapy in premenopausal breast cancer patients.

P. Morandi, M. Gunduz, O. Altundag, 2005, Annals of oncology : official journal of the European Society for Medical Oncology.

Introduction Left laterality is an independent prognostic factor for metastasis in N 3 stage breast cancer

Y. Ozisik, A. Sever, S. Şahin, 2016 .

Obesity is an independent prognostic factor of decreased pathological complete response to neoadjuvant chemotherapy in breast cancer patients.

Y. Ozisik, A. Sever, D. Yuce, 2017, Breast.

Prognosis of breast cancer in patients with peritoneal metastasis.

U. Şahin, M. Karçaaltıncaba, V. Ayyıldız, 2012, Breast.

The role of zoledronic acid in the adjuvant treatment of breast cancer: current perspectives

K. Altundag, Ç. Arslan, O. Tonyali, 2010, Expert opinion on pharmacotherapy.

Calcium and vitamin D supplementation during bisphosphonate administration may increase osteoclastic activity in patients with bone metastasis.

K. Altundag, M. Gunduz, O. Altundag, 2004, Medical hypotheses.

Evaluation of changes of biologic markers ER, PR, HER 2 and Ki-67 in breast cancer with administration of neoadjuvant dose-dense doxorubicin, cyclophosphamide followed by paclitaxel.

K. Altundag, Y. Ozisik, G. Guler, 2013, Journal of B.U.ON. : official journal of the Balkan Union of Oncology.

Pentoxifylline and alpha-tocopherol in prevention of radiation-induced lung toxicity in patients with lung cancer

T. Demirkasimoğlu, E. Sanri, K. Altundağ, 2007, Medical oncology.

Nanobacteria and Breast Implant Capsule Contracture and Calcification: A Hypothesis

O. Altundag, Ozlem A Gundeslioglu, K. Altundağ, 2005, Aesthetic Plastic Surgery.

Isolated granulocytic sarcoma of the head and neck preceding acute myeloid leukemia

C. Chiang, O. Karadag, O. Dikbas, 2004, American journal of hematology.

Anal Tumor Diagnosed After the Recovery of Fournier Gangrene

M. Altundağ, T. Demirkasimoğlu, Y. Elgin, 2006, Digestive Diseases and Sciences.

Ipsilateral Breast Cancer in a Patient with Poland's Syndrome

O. Dizdar, Y. Yeşilkaya, K. Altundağ, 2011, The American surgeon.

Impact of Acetylsalicylic Acid on the Clinicopathological Characteristics and Prognosis of Patients with Invasive Breast Cancer

N. Zengi̇n, S. Aksoy, M. Şendur, 2014, Breast Care.

Evaluation of erectile dysfunction risk factors in young male survivors of colorectal cancer.

O. Yazıcı, N. Zengi̇n, S. Aksoy, 2014, Journal of B.U.ON. : official journal of the Balkan Union of Oncology.

Effect of concomitant use of pentoxifylline and alpha-tocopherol with radiotherapy on the clinical outcome of patients with stage IIIB non-small cell lung cancer

Y. Elgin, Handan Erkal, I. Uğur, 2006, Medical oncology.

The effect of obesity on recurrence pattern in early breast cancer patients.

K. Altundag, Y. Ozisik, O. Yazıcı, 2015, Journal of B.U.ON. : official journal of the Balkan Union of Oncology.

Outcomes of locally advanced breast cancer patients with ≥10 positive axillary lymph nodes

O. Dizdar, I. Sahin, T. Babacan, 2013, Medical Oncology.

Neoadjuvant Chemotherapy with Cyclophosphamide, Mitoxantrone, and 5-Fluorouracil in Locally Advanced Breast Cancer

Y. Ozisik, N. Guler, I. Sayek, 2005, Oncology Research and Treatment.

Weekly paclitaxel in the adjuvant treatment of breast cancer.

O. Dizdar, S. Aksoy, K. Altundağ, 2008, The New England journal of medicine.

Promising therapeutic options in triple-negative breast cancer.

A. Bilici, Ç. Arslan, K. Altundağ, 2012, Journal of B.U.ON. : official journal of the Balkan Union of Oncology.

Does letrozole have any place in adjuvant setting in breast cancer patients with documented hypercoagulability?

K. Altundag, Y. Ozisik, B. Oyan, 2004, American journal of clinical oncology.

Impact of locoregional treatment on survival in patients presented with metastatic breast carcinoma.

K. Altundag, Y. Ozisik, N. Guler, 2014, Breast.

PO-0699: Impact of locoregional treatment on survival in patients presented with metastatic breast carcinoma

K. Altundag, Y. Ozisik, N. Guler, 2014 .

Late local recurrences in a randomized trial comparing conservative treatment with total mastectomy in early breast cancer patients: the impact of receptor status on local relapse.

O. Altundag, M. Altundağ, K. Altundağ, 2004, Annals of oncology : official journal of the European Society for Medical Oncology.

Salvage ifosfamide-doxorubicin chemotherapy in patients with recurrent nasopharyngeal carcinoma pretreated with cisplatin-based chemotherapy

K. Altundag, E. Ozyar, O. Altundag, 2004, Medical oncology.

Complete response and long-term remission to anti-HER2 combined therapy in a patient with breast cancer presented with bone marrow metastases

M. C. Boruban, H. Toy, M. Artaç, 2014, Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners.

The lymph node ratio as an independent prognostic factor for non-metastatic node-positive breast cancer recurrence and mortality.

A. Sever, T. Babacan, S. Aksoy, 2015, Journal of B.U.ON. : official journal of the Balkan Union of Oncology.

Associations among physical activity, comorbidity, functional capacity, peripheral muscle strength and depression in breast cancer survivors.

Y. Ozisik, Deniz Inal-Ince, Ebru Calik-Kutukcu, 2015, Asian Pacific journal of cancer prevention : APJCP.

A systemic late recurrence after the first operation in a patient diagnosed with early-stage breast cancer: the latest recurrence in the literature.

K. Altundag, Z. Arık, T. Babacan, 2015, Journal of B.U.ON. : official journal of the Balkan Union of Oncology.

ERCC1 expression in triple negative breast cancer.

G. Guler, S. Aksoy, Ş. Yaman, 2012, Journal of B.U.ON. : official journal of the Balkan Union of Oncology.

Prophylactic human papilloma virus vaccines for cervical cancer may also prevent development of breast and oropharyngeal cancers in women.

H. Harputluoglu, O. Dizdar, K. Altundağ, 2006, Medical hypotheses.

Albumin-bound paclitaxel (ABI-007; Abraxane) in the management of basal-like breast carcinoma

K. Altundag, T. Purnak, D. Dede, 2006, Journal of Clinical Pathology.

Does breast cancer associated with CHEK2 1100delC carry characteristics of basal phenotype?

N. Bulut, E. Sarı, D. Dede, 2007, Breast Cancer Research and Treatment.

Comment on “Chemotherapy-Induced Left Ventricular Dysfunction in Patients with Breast Cancer”

K. Altundağ, 2017, Journal of Breast Cancer.

Estrogen receptor immunohistochemistry cutoff value: standardization is needed.

K. Altundag, O. Dizdar, Ç. Arslan, 2010, Human pathology.

Increased mean corpuscular volume of erythrocytes predicts the response to metronomic cyclophosphamide, capecitabine and bevacizumab treatment: is it true for capecitabine treatment or more?

Ç. Arslan, K. Altundağ, 2012, Breast.

Clinical features associated with a favorable outcome following neoadjuvant chemotherapy in women with localized breast cancer aged 35 years or younger

Terry L. Smith, G. Hortobagyi, V. Valero, 2008, Journal of Cancer Research and Clinical Oncology.

Indolent triple negative breast cancer patients are more likely to develop late relapse compared to triple negative breast cancer patients with a high proliferation index.

K. Altundağ, 2023, Breast.

Obesity may be a independent prognostic factor in premenopausal breast cancer patients.

K. Altundag, P. Morandi, M. Gunduz, 2004, Breast.

Bradycardia during induction therapy with all-trans retinoic acid ( ATRA )

T. Babacan, A. Kars, E. Aladağ, 2014 .

Granulocytic sarcoma of the urinary bladder

G. Tekuzman, A. Sağlam, K. Altundağ, 2004, American journal of hematology.

Statin use may improve clinicopathological characteristics and recurrence risk of invasive breast cancer

O. Yazıcı, N. Zengi̇n, S. Aksoy, 2014, Medical Oncology.

Smoking status and adenocarcinoma histology may explain an improved survival in the female non-small cell lung cancer patients.

P. Morandi, M. Gunduz, O. Altundag, 2005, Lung cancer.

Association between epidermal growth factor receptor mutation and improved survival in never-smokers with primary adenocarcinoma of the lung.

K. Altundag, P. Morandi, M. Gunduz, 2005, Chest.

Leptin and breast cancer: an overview

K. Altundag, M. Artaç, K. Altundağ, 2012, Medical Oncology.

Trastuzumab in metastatic breast cancer after complete remission: How long is enough?

O. Altundag, A. Oğuz, S. Rahatli, 2015, Medical Oncology.

Metastatic pure invasive lobular breast cancer or metastatic mixed invasive ductal and lobular breast cancer: are they different entities?

K. Altundağ, 2023, Breast Cancer Research and Treatment.

Pamidronate, hypocalcemia, and calcium and vitamin D supplementation.

K. Altundag, O. Altundag, K. Altundağ, 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Association between Tumor Characteristics and Bone Mineral Density in Postmenopausal Breast Cancer Patients

K. Altundag, B. Arun, K. Broglio, 2013, The breast journal.

Malignancies after rituximab treatment: just coincidence or more?

H. Harputluoglu, O. Dizdar, S. Aksoy, 2011, Journal of B.U.ON. : official journal of the Balkan Union of Oncology.

Characteristics of Patients With Breast Cancer With Brain Metastases Who Live Longer Than 60 Months.

K. Altundağ, 2019, Clinical breast cancer.

Characteristics of breast cancer patients with brain metastases who live longer than 18 months.

K. Altundağ, 2017, Breast.

Long-term survivors among breast cancer patients with brain metastases.

Z. Arık, S. Aksoy, E. Doğan, 2010, Annals of oncology : official journal of the European Society for Medical Oncology.

Prognostic factors in long-term breast cancer survivors with brain metastases

H. Harputluoglu, O. Dizdar, A. Kara, 2008, Breast Cancer Research and Treatment.

Prognostic factors in breast cancer patients with brain metastases

H. Harputluoglu, O. Dizdar, K. Altundağ, 2008, Journal of Neuro-Oncology.

Hormone receptor status as an independent variable affecting the survival of advanced breast cancer patients with brain metastases.

H. Harputluoglu, M. Cengiz, K. Altundağ, 2007, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Hormone receptor status as a prognostic factor affecting the outcome of brain metastases

H. Harputluoglu, T. Purnak, K. Altundağ, 2007, Supportive Care in Cancer.

Probable hepatotoxicity related to Nerium oleander extract in a patient with metastatic synovial sarcoma of the knee.

Y. Kalpakçı, E. Doğan, B. Bitik, 2009, Journal of alternative and complementary medicine.

Other malignancies in patients with breast cancer: a single institute experience

Y. Ozisik, O. Dizdar, S. Aksoy, 2010, Medical oncology.

Possible association between Budd‐Chiari syndrome and gemtuzumab ozogamicin treatment in a patient with refractory acute myelogenous leukemia

K. Altundag, E. Kansu, M. Kurt, 2005, American journal of hematology.

Zoledronic acid and atrial fibrillation in cancer patients

H. Harputluoglu, O. Dizdar, S. Aksoy, 2011, Supportive Care in Cancer.

Comparison of prognosis and clinical features between synchronous bilateral and unilateral breast cancers.

K. Altundag, S. Aksoy, N. Kertmen, 2017, Journal of B.U.ON. : official journal of the Balkan Union of Oncology.

EGFR expression and gene copy number in triple-negative breast carcinoma.

G. Guler, S. Hucumenoglu, B. Gumuskaya, 2010, Cancer genetics and cytogenetics.

Immune evasion might affect survival in laryngeal cancer patients with blood group O

K. Altundağ, 2017, Chinese journal of cancer.

The Effect of Total Size of Lesions in Multifocal/Multicentric Breast Cancer on Survival

O. Dizdar, M. Hayran, S. Aksoy, 2017, Clinical breast cancer.

Comparative efficacy study of 5-year letrozole or anastrozole in postmenopausal hormone receptor-positive early breast cancer.

K. Altundag, N. Zengi̇n, S. Aksoy, 2013, Journal of B.U.ON. : official journal of the Balkan Union of Oncology.

Preoperative Doppler sonography for prevention of perioperative stroke in head and neck cancer patients undergoing neck dissection: Is it beneficial?

Mustafa A. Atik, O. Altundag, N. Akkuş, 2007, Journal of clinical ultrasound : JCU.

Effects of tamoxifen on urinary incontinence

E. Jonasch, K. Altundag, R. Hasanov, 2017, Medicine.

Demographic and clinico-pathological characteristics of breast cancer patients with history of oral alendronate use

K. Altundag, Z. Arık, N. Zengi̇n, 2012, Medical Oncology.

Some pathological and clinical factors are important to describe association between Ki67 expression and recurrences in breast cancer patients receiving neoadjuvant chemotherapy.

K. Altundağ, 2017, Human Pathology.

The higher incidence of cases with poor prognostic factors in breast cancer patients who developed both breast cancer‐related lymphedema and cellulitis might explain higher mortality

K. Altundağ, 2022, Journal of surgical oncology.

Phase II Study of Loading-Dose Ibandronate Treatment in Patients with Breast Cancer and Bone Metastases Suffering from Moderate to Severe Pain

K. Altundag, O. Dizdar, Z. Ozsaran, 2012, Oncology Research and Treatment.

Handedness and breast cancer characteristics.

K. Altundag, A. Sever, M. Işık, 2016, Journal of B.U.ON. : official journal of the Balkan Union of Oncology.

Intracystic Papillary Carcinoma: A Rare Clinical Entity

M. C. Kızılarslanoğlu, E. Roach, G. Gezgen, 2011, The American surgeon.

Re: Unusual Cause of Horner Syndrome 13 Years After In Situ Ductal Carcinoma

K. Altundağ, 2017, Neuro-ophthalmology (Aeolus Press. 1980).

Current management of aromatase inhibitor-induced arthralgia.

A. Sever, S. Şahin, Fatih Karataş, 2016, Journal of B.U.ON. : official journal of the Balkan Union of Oncology.

Association between androgen receptor status and prognosis in triple negative breast cancer.

K. Altundag, S. Aksoy, F. Sarici, 2018, Journal of B.U.ON. : official journal of the Balkan Union of Oncology.

How can Nolvadex abolish arthralgia in women taking newer generic Tamoxifen preparations?

I. Sahin, E. Ararat, K. Altundağ, 2010, Breast.

Efficacy of anastrozole on local recurrence in patients with favorable early breast cancer.

H. Harputluoglu, O. Dizdar, K. Altundağ, 2007, International journal of radiation oncology, biology, physics.

Leg cramps associated with tamoxifen use--possible mechanism and treatment recommendations.

A. Sever, S. Şahin, T. Babacan, 2016, Journal of B.U.ON. : official journal of the Balkan Union of Oncology.

Medulloblastoma/primitive neuroectodermal tumor in adults: prognostic factors and treatment results: a single-center experience from Turkey

T. Çalikoglu, Sema Durmuş, M. Altundağ, 2008, Medical oncology.

Brain specific progression free survival (bsPFS) according to breast cancer subtypes in patients with brain metastases.

O. Yazıcı, S. Aksoy, Ç. Arslan, 2015 .

Efficacy and safety evaluation of eribulin-trastuzumab combination therapy with heavily pretreated HER2-positive metastatic breast cancer.

F. Sarici, K. Altundağ, 2020, Journal of B.U.ON. : official journal of the Balkan Union of Oncology.

Flap Fixation Using Tissue Glue or Sutures After Mastectomy Might Also Reduce Risk of Developing Lymphedema in Breast Cancer.

K. Altundağ, 2017, Clinical breast cancer.

The impact of efficacy of receptor conversion on metastases directed therapies in liver metastases with breast cancer.

K. Altundağ, 2021, Journal of B.U.ON. : official journal of the Balkan Union of Oncology.

Selenium supplementation may increase the efficacy of cetuximab in metastatic colorectal cancer patients.

O. Yiğitbaşı, M. Gunduz, O. Altundag, 2005, Medical hypotheses.

Physical activity and breast cancer: Role of inhibition of Wnt signaling in triple negative breast cancer.

K. Altundağ, 2020, Journal of B.U.ON. : official journal of the Balkan Union of Oncology.

Possible interaction between activator protein-1 and proto-oncogene B-cell lymphoma gene 6 in breast cancer patients resistant to tamoxifen.

K. Altundag, B. Arun, M. Gunduz, 2004, Medical hypotheses.

Hormone receptor status of primary tumor as a prognostic factor in patients with liver metastases from breast cancer treated with transcatheter arterial chemoembolization.

O. Altundag, C. Boruban, Ozlem Yavas, 2005, World Journal of Gastroenterology.

Hormone receptor status in patients with breast cancer and liver metastases treated with laser-induced intersititial thermotherapy.

P. Morandi, M. Gunduz, O. Altundag, 2005, Radiology.

Efficacy of angiotensin-receptor blockers on demographic and clinico-pathological characteristics of breast cancer.

N. Zengi̇n, S. Aksoy, M. Şendur, 2012, Breast.

The effect of renin-angiotensin-system inhibition on survival and recurrence of N3+ breast cancer patients.

T. Babacan, N. Kertmen, O. Balakan, 2015, Journal of B.U.ON. : official journal of the Balkan Union of Oncology.

Efficacy of Palbociclib and Endocrine Treatment in Heavily Pretreated Hormone Receptor-positive/HER2-negative Advanced Breast Cancer: Retrospective Multicenter Trial

G. Basaran, S. Paydaş, Meral Günaldı, 2020, Balkan medical journal.

Efficacy of Palbociclib and Endocrine Treatment in Heavily Pretreated Hormone Receptor-positive/HER2-negative Advanced Breast Cancer: Retrospective Multicenter Trial

G. Basaran, S. Paydaş, Meral Günaldı, 2020, Balkan Medical Journal.

Aromatase inhibitor-associated arthralgia: Prevalence, clinical and serum parameters among Turkish postmenopausal breast cancer patients

H. Harputluoglu, Y. Ozisik, O. Dizdar, 2008 .

Response to taxanes in triple negative breast cancer

S. Kılıçkap, N. Bulut, E. Sarı, 2008, Cancer Chemotherapy and Pharmacology.

How can we use anthracylines in the management of newly diagnosed metastatic breast cancer patients overexpressing HER-2?

H. Harputluoglu, K. Altundağ, 2008, Annals of oncology : official journal of the European Society for Medical Oncology.

Heparanase activity and bone loss in postmenopausal breast cancer patients.

O. Altundag, M. Baptista, S. Akyurek, 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Does estrogen receptor determination affect prognosis in early stage breast cancers?

N. Bulut, K. Altundağ, 2015, International journal of clinical and experimental medicine.

Unusual location of hydatid cyst: soft tissue mass in the neck

T. Delibaşı, A. Celik, S. Aslan, 2006, European Archives of Oto-Rhino-Laryngology and Head & Neck.

Possible Association between Nanobacteria and Malignant Microcalcifications in Breast Cancer

Mustafa A. Atik, O. Altundag, S. Akyurek, 2006, The breast journal.

Correlation of educational status and clinicopathological characteristics of breast cancer: a single center experience.

K. Altundag, O. Unlu, A. Sever, 2015, Journal of B.U.ON. : official journal of the Balkan Union of Oncology.

Value of Dynamic 18F-FDG PET/CT in Predicting the Success of Neoadjuvant Chemotherapy in Patients with Locally Advanced Breast Cancer: A Prospective Study

M. Tuncel, B. Erbaş, M. Akpınar, 2023, Molecular imaging and radionuclide therapy.

The relationship between occupations and head and neck cancers.

R. Akdur, M. Cengiz, T. Pınar, 2007, Journal of the National Medical Association.

Electrolyte abnormalities due to irinotecan administration in metastatic HER-2 positive breast cancer patients.

Y. Ozisik, I. Petekkaya, E. Roach, 2012, Journal of B.U.ON. : official journal of the Balkan Union of Oncology.

Albumin-Bound Paclitaxel, ABI-007 May Show Better Efficacy than Paclitaxel in Basal-Like Breast Cancers: Association Between Caveolin-1 Expression and ABI-007

H. Harputluoglu, K. Altundag, O. Dizdar, 2006, Breast Cancer Research and Treatment.

CA125 Nadir values as a prognostic factor in epithelial ovarian cancer.

P. Morandi, M. Gunduz, O. Altundag, 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Imatinib mesylate lacks activity in small cell lung carcinoma expressing c‐kit protein: A phase II clinical trial

K. Altundag, O. Altundag, C. Boruban, 2005, Cancer.

Embryonal Rhabdomyosarcoma of the Larynx

A. Sungur, H. Abalı, H. Engin, 2005, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.

Some concerns about the prognostic significance of non-lymphoid immune cells of the tumor microenvironment in breast carcinomas.

K. Altundağ, 2023, Annals of diagnostic pathology.

Challenge in the treatment of estrogen-receptor-negative ductal carcinoma in situ.

K. Altundağ, 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Can all beta blockers improve the breast cancer survival?

Z. Arık, S. Aksoy, M. Şendur, 2012, Breast.

Mechanisms behind the anti‐tumour effects of zoledronic acid use in multiple myeloma

I. Sahin, E. Ararat, E. Ozdemir, 2010, British journal of haematology.

Nine weeks versus 1 year adjuvant trastuzumab in patients with early breast cancer: an observational study by the Turkish Oncology Group (TOG)

C. Sezgin, R. Uslu, B. Demirkan, 2015, Breast Cancer.

K. Altundağ, 2019, Supportive Care in Cancer.

A positive conversion in Hormone Receptor and HER2 status and other metastatic sites might have a impact on survival for breast cancer patients with ovarian metastases.

K. Altundağ, 2021, Journal of Gynecology Obstetrics and Human Reproduction.

Is there any association between absolute lymphocyte count and increased tumor-infiltrating lymphocytes in metastatic sites in advanced breast cancer patients who get benefit from eribulin treatment?

K. Altundağ, 2020, Breast Cancer Research and Treatment.

Better pathological tumor characteristics might occur in recurrent metastatic breast cancer patients after 10-year metastatic free interval

K. Altundağ, 2018, Breast Cancer Research and Treatment.

Elevated BMI might more significantly affect the outcome negatively in luminal type breast cancer patients with brain metastases

K. Altundağ, 2018, Breast Cancer Research and Treatment.

Receptor conversion in breast cancer brain metastases may affect survival

K. Altundağ, 2018, Clinical neurology and neurosurgery (Dutch-Flemish ed. Print).

Receptor conversion in breast cancer patients with liver metastases after hepatectomy might affect survival

K. Altundag, K. Altundağ, 2018, Breast cancer research and treatment.

A positive conversion in hormone receptor and HER2 status might have an impact on survival after liver resection for breast cancer metastases

K. Altundağ, 2018, Irish Journal of Medical Science.

A Positive Conversion in HER2 Status Might Affect Survival after Liver Resection for Breast Cancer Metastases

K. Altundağ, 2018, Digestive Surgery.

Tumor types, breast tumor subtypes and extension of systemic disease may influence outcome in cancer patients with brain metastases

K. Altundağ, 2017, Journal of Neuro-Oncology.

Dietary Phytochemical Index and the Risk of Breast Cancer: A Case-Control Study

K. Altundağ, E. Yıldız, Aylin Acikgoz Pinar, 2022, Nutrition and cancer.

Erythropoiesis-stimulating agents in the treatment of cancer-associated anemia.

O. Dizdar, O. Kara, K. Altundağ, 2008, JAMA.

Treatment of comorbidities besides the treatment of primary tumor may further increase effective management of cancer.

H. Harputluoglu, S. Kılıçkap, S. Aksoy, 2006, Medical hypotheses.

Successful treatment of primary duodenal carcinoma with bilateral adrenal metastases with docetaxel-cisplatin-5-fluorouracil regimen.

Y. Kalpakçı, E. Doğan, B. Bitik, 2008, Annals of oncology : official journal of the European Society for Medical Oncology.

HER2 status might be independent determinant associated with no residual disease at surgical resection in patients with DCIS

K. Altundağ, 2017, Journal of surgical oncology.

A retrospective analysis of adjuvant CAF, AC-T and TAC regimens in triple negative early stage breast cancer.

Y. Ozisik, T. Babacan, N. Kertmen, 2015, Journal of B.U.ON. : official journal of the Balkan Union of Oncology.

Why Adjuvant Trastuzumab Led to Better Outcomes in Women with High‐Risk HER‐2‐Positive Breast Cancer

M. Baptista, K. Altundağ, 2006, The breast journal.

Rationale for the use of trastuzumab in patients with cerebral metastases who previously receive trastuzumab-based therapy for metastatic breast cancer.

P. Morandi, M. Gunduz, Mustafa A. Atik, 2005, Breast.

Role of trastuzumab in patients with brain metastases from Her2 positive breast cancer

H. Harputluoglu, O. Dizdar, N. Bulut, 2007, Journal of Neuro-Oncology.

Influence of Smoking History on Breast Cancer Prognosis: Retrospective Study of 240 Operable Breast Cancer Patients Who Received Adjuvant Cyclophosphamide, Doxorubicin, and 5‐Fluorouracil Chemotherapy Regimen

H. Harputluoglu, Y. Ozisik, N. Guler, 2007, The breast journal.

Potential targeted therapy options in the management of basal cell subtype of breast carcinoma.

H. Harputluoglu, O. Dizdar, K. Altundağ, 2007, Human pathology.

Why osteonecrosis of the jaw after bisphosphonates treatment is more frequent in multiple myeloma than in solid tumors.

T. Delibaşı, K. Altundağ, Yesim Kanlioglu, 2006, Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons.

Cetuximab-induced esophageal ulcer: the first report in literature

K. Altundag, T. Babacan, I. Turkbeyler, 2014, The Libyan journal of medicine.

Endocrine Treatment Is Still the Main Option in the Management of Metastatic Breast Cancer Patients with Liver-Dominant Metastases.

K. Altundağ, 2016, Journal of Vascular and Interventional Radiology.

Cisplatin as a radiosensitizer in the treatment of locally advanced head and neck cancer.

P. Morandi, O. Altundag, E. Hanrahan, 2005, Oral Oncology.

Cyclooxygenase-2 inhibitor and cisplatin combination as a radiosensitizer in the treatment of head and neck cancer patients.

P. Morandi, M. Gunduz, O. Altundag, 2004, Annals of oncology : official journal of the European Society for Medical Oncology.

Unilateral Diaphragm Paralysis Possibly Due to Cervical Spine Involvement in Multiple Myeloma

S. Aksu, O. Erol, S. Doğan, 2006, Medical Principles and Practice.

Vitamin D supplementation and response to aromatase inhibitors in postmenopausal women with hormone-receptor positive breast cancer.

O. Dizdar, N. Bulut, K. Altundağ, 2008, Breast.

Differential alteration of drug metabolizing enzyme activities after cyclophosphamide/adriamycin administration in breast cancer patients

T. Elkıran, H. Harputluoglu, U. Yasar, 2007, Methods and findings in experimental and clinical pharmacology.

Breast cancer in a patient with agnogenic myeloid metaplasia.

Z. Arık, E. Ozdemir, C. Ozkan, 2010, Southern medical journal.

The association between neutrophil to lymphocyte ratio and survival in metastatic breast cancer patients.

O. Unlu, E. Petekkaya, P. Kubelac, 2016, Journal of B.U.ON. : official journal of the Balkan Union of Oncology.

Safety Analysis of Premenopausal Breast Cancer Patients in PALOMA‐3 Study: Is It Worth Mentioning?

K. Altundağ, 2017, The oncologist.

MRI in breast cancer.

P. Morandi, O. Altundag, K. Altundağ, 2004, The New England journal of medicine.

Histopathological definition of medullary breast cancer should be revisited.

K. Altundağ, 2017, Journal of B.U.ON. : official journal of the Balkan Union of Oncology.

Gastric cancer and the coincidental finding of herpetic esophagitis immediately after pregnancy: a case report.

S. Cizginer, M. Kurt, S. Aksoy, 2007, The Journal of reproductive medicine.

Is there any association between use of granulocyte colony-stimulating factor and chemotherapy-induced oral mucositis?

K. Altundağ, 2018, European Journal of Cancer Care.

Increased pathologic complete response are expected in HER2-positive and triple-negative locally advanced breast cancers

K. Altundag, K. Altundağ, 2017, Chinese journal of cancer.

Genomic Profiling of Brain Metastasis and Matched Primary Triple-negative Breast Cancer.

K. Altundağ, 2017, Clinical Breast Cancer.

Post-diagnosis statin use and breast recurrence sites in early stage breast cancer survivors

H. Harputluoglu, O. Dizdar, F. Karaahmet, 2008, Breast Cancer Research and Treatment.

Behçet's disease and breast cancer: A case series study

S. Şahin, S. Aksoy, A. Aytekin, 2018, Journal of cancer research and therapeutics.

Metastatic occult breast carcinoma to gallbladder initially presenting as acute cholecystitis.

K. Altundag, K. Altundağ, 2021, Journal of B.U.ON. : official journal of the Balkan Union of Oncology.

Breast Cancer Molecular Subtypes and Chemotherapy Schedules Used in Neoadjuvant or Adjuvant Setting May Show Different Effects in Nipple-Sparing Mastectomy.

K. Altundağ, 2017, Plastic and Reconstructive Surgery.

Inactivation of E-cadherin and less sensitivity of lobular breast carcinoma cells to chemotherapy.

O. Altundag, E. Karakaya, S. Akyurek, 2006, Breast.

Triple-negative breast cancer and brain metastases.

K. Altundag, E. Çinar, B. Sait, 2010, Clinical oncology (Royal College of Radiologists (Great Britain)).

Extramedullary plasmacytoma of nasopharynx and larynx: Synchronous presentation

A. Sungur, Ozlem Yavas, K. Altundağ, 2004, American journal of hematology.

Comment on “Histomorphological Factors Predicting the Response to Neoadjuvant Chemotherapy in Triple-Negative Breast Cancer”

K. Altundağ, 2017, Journal of Breast Cancer.

Demographic and clinico-pathological characteristics in patients with triple-negative and non-triple-negative breast cancer

O. Dizdar, I. Gullu, S. Aksoy, 2011, Medical oncology.

Medullary carcinoma of the breast: a brief report from a tertiary care center.

T. Babacan, M. C. Kızılarslanoğlu, I. Petekkaya, 2012 .

Questions about the primary tumor resection for de-novo metastatic breast cancers.

K. Altundağ, 2019, Cancer treatment and research communications.

Predictive role of loco-regional radiotherapy among metastatic breast cancer patients who had undergone primary tumor surgery

K. Altundağ, 2017, Breast Cancer Research and Treatment.

Blood ABO groups and risk of breast cancer

O. Dizdar, I. Gullu, S. Aksoy, 2010, Medical oncology.

Clinical characteristics and outcome of patients with stage III esophageal carcinoma: a single-center experience from Turkey

T. Demirkasimoğlu, V. I. Uğur, Y. Elgin, 2008, Medical oncology.

Combination Treatment of Vinorelbine With Oral Cyclophosphamide or Capecitabine or Both Might Overcome Cross-resistance Against Eribulin in Advanced Breast Cancer.

K. Altundağ, 2022, Clinical breast cancer.

Synchronous ovarian cancer in a patient with pleomorphic lobular breast cancer: a therapeutic dilemma.

O. Dizdar, Ç. Arslan, K. Altundağ, 2010, Clinical oncology (Royal College of Radiologists (Great Britain)).

The role of zoledronic acid in the adjuvant treatment of breast cancer: current perspectives

Ç. Arslan, O. Tonyali, K. Altundağ, 2010, Expert opinion on pharmacotherapy.

Clinical and Pathological Characteristics of Breast Cancer Patients with History of Appendectomy

S. Aksoy, K. Altundağ, Metin Isik, 2011, The American surgeon.

New Data About First-line All-oral Vinorelbine and Capecitabine in HER2-negative Metastatic Breast Cancer Confirms Results of Meta-analysis.

K. Altundağ, 2017, Clinical breast cancer.

Comment to “Patients with Concordant Triple-Negative Phenotype between Primary Breast Cancers and Corresponding Metastases Have Poor Prognosis”

K. Altundag, K. Altundağ, 2016, Journal of breast cancer.

Acute promyelocytic leukemia in a young patient with breast cancer

K. Altundag, O. Kara, E. Ozdemir, 2011, Medical oncology.

Serum endocan level and its prognostic significance in breast cancer patients

V. Sunar, O. Ates, E. Gedik, 2018 .

Clinical implications of intratumoral heterogeneity of HER2 gene amplification in locally advanced HER2-positive breast cancer patients.

A. Sever, S. Akın, K. Altundağ, 2015, Future oncology.